News

U.S. FDA sends drug advertising warning letters to Lilly, Novo, Hims

The U.S. Food and Drug Administration issued warning letters to Eli Lilly , Novo Nordisk and telehealth firm Hims & Hers ...
Scientific American

Alzheimer’s Drugs Are Finally Tackling the Disease Itself. Here’s How

While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 ...

Why Weight-Loss Drugs Alone Won’t Make Us Healthy

We are entering a new era of obesity. The science of weight loss has changed forever: Drugs like Ozempic, Wegovy, and ...
STAT

9 answers to burning questions about pharmaceutical ads

On top of that, drug ads must provide “fair balance,” meaning the positives and negatives have to both be presented. In ...

Fact check: COVID vaccines are harder to get, despite claims from HHS, RFK Jr.

Kennedy claimed during a hearing that anyone who wants the COVID vaccine can get it, but changes to vaccine policy suggest ...

Why microdosing Ozempic could become as common as taking a multivitamin

GLP-1 medications like Ozempic show promise for multiple health conditions, as experts explore microdosing benefits for blood ...

Marijuana linked to chromosomal defects in human egg cells, study finds

A June study found that past-month self-reported cannabis use has more than tripled among pregnant women in the United States ...
SanLuisObispo

Recall: The label says muscle relaxer, but arthritis drugs are in the bottle

Unichem Pharmaceuticals has recalled one lot of a muscle relaxer because the pills in the bottle might not be the muscle relaxer on the label. The East Brunswick, New Jersey, company’s FDA-posted ...